Virtu Financial’s Soleno Therapeutics, Inc. Series A Warrant SLNOW Stock Holding History

Virtu Financial’s Portfolio SLNOW Stock Details SLNOW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	–	Sell	-2,503	Closed	-$1K	–	3421
2017 Q3	$1K	Buy	+2,503	New	+$1.46K	﹤0.01%	2464

Other funds holding SLNOW

Vivo Capital Palo Alto, California $1.2B AUM 911.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Virtu Financial's SLNOW Position: Q4 2017 in Review

Virtu Financial sold out of Soleno Therapeutics, Inc. Series A Warrant (SLNOW) in Q4 2017, closing a stake of 2,503 shares — an estimated $1K sold.

Virtu Financial first reported a position in SLNOW in Q3 2017 and held it in 1 quarter. The position peaked at $1K in Q3 2017. 3 funds tracked by Wall St. Rank hold SLNOW as of Q4 2017.

Virtu Financial reported no remaining Soleno Therapeutics, Inc. Series A Warrant position as of Q4 2017 after selling out during the quarter.
Virtu Financial sold 2,503 Soleno Therapeutics, Inc. Series A Warrant shares in Q4 2017, an estimated $1K.
Virtu Financial first reported a position in Soleno Therapeutics, Inc. Series A Warrant in Q3 2017 and held it in 1 quarter.
Virtu Financial's Soleno Therapeutics, Inc. Series A Warrant position peaked at $1K in Q3 2017.
3 funds tracked by Wall St. Rank held Soleno Therapeutics, Inc. Series A Warrant as of Q4 2017.

Based on Virtu Financial's 13F filing for Q4 2017, filed 9 Feb 2018.